The cardiovascular care of thousands of Missouri patients is suddenly up in the air. The heart of the issue is a practice's alleged interest in opening up a new private equity-backed clinic.  

An interventional cardiologist believes he was targeted and terminated for being outspoken about a series of incidents at his hospital. 

The approval, made as part of a special FDA pilot program, took just 50 days.

ACC.26 Chair Kathryn Berlacher, MD, MS, explained some of the big trends at this year's meeting, including AI, CCTA, hands-on training and guideline sessions.

Lower Medicare drug costs translated into more patients taking their medications, leading to better outcomes.

New pacing system is designed to streamline TAVR cath lab workflows, cut procedural steps and increase reliability.

The new device, which provides users with real-time images in full color, is now approved by the FDA to be used in the peripheral vasculature. Meanwhile, first-in-human data published in Stroke explored its potential in the cerebral vasculature. 

The cardiovascular mortality rate in the United States decreased dramatically from 2000 to 2011. Since then, however, it has remained relatively unchanged.

The newly cleared device was built to provide support, trackability and stability during the treatment of time-sensitive stroke patients. 

On Tuesday, a judge formally rejected a motion by the company to have the case dismissed. Carelon Behavioral Health, a subsidiary of Elevance, is accused of publishing an inaccurate directory of providers for those seeking mental health services.

In particular, rads working in breast imaging and pediatrics appear to notch the lowest rates of career advancement, experts write in Current Problems in Diagnostic Radiology.